THC Stock Recent News
THC LATEST HEADLINES
Tenet Healthcare Corporation (NYSE:THC ) Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ET Company Participants Will McDowell - Vice President of Investor Relations Saumya Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrew Mok - Barclays Justin Lake - Wolfe Research Benjamin Rossi - JPMorgan Chase Joanna Gajuk - Bank of America A.J Rice - UBS Stephen Baxter - Wells Fargo Michael Ha - Baird Ann Hynes - Mizuho Whit Mayo - Leerink Partners John Ransom - Raymond James Josh Raskin - Nephron Research Matthew Gillmor - KeyBanc Mike Murray - RBC Capital Markets Operator Good morning. Welcome to Tenet Healthcare's Fourth Quarter 2024 Earnings Conference Call.
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tenet Healthcare (THC) came out with quarterly earnings of $3.44 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.68 per share a year ago.
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2024. "2024 was an outstanding year for Tenet characterized by robust revenue growth, efficient operations, high levels of patient satisfaction and clinical quality, and a portfolio transformation that drove substantial balance sheet deleveraging," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Our focused strategy, disciplined operat.
THC's fourth-quarter results are likely to reflect growing patient admissions, utilization and patient days.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Tenet Healthcare (THC) closed the most recent trading day at $143.71, moving -0.64% from the previous trading session.
The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these trends.
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.